Cite
APA Citation
Albisetti, M., Schlosser, A., Brueckmann, M., Gropper, S., Glund, S., Tartakovsky, I., Brandão, L. R., & Reilly, P. A. (2018). rationale and design of a phase III safety trial of idarucizumab in children receiving dabigatran etexilate for venous thromboembolism. Research and practice in thrombosis and haemostasis, 2(1), 69–76. http://access.bl.uk/ark:/81055/vdc_100057092038.0x000003